ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10.

Jame Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.